IP Library Granted Patent US 8,163,529
Granted Patent B2
US 8,163,529 · App. 12/906,515 · Granted Apr 24, 2012

Nicking endonuclease methods and compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,529
App. No.
12/906,515
Granted
Apr 24, 2012
Kind
B2
Abstract

A nicking endonuclease is described which has an amino acid sequence with at least 70% identity to SEQ ID NO:6 and comprising a mutation at least one of an arginine or glutamic acid corresponding to position 507 and position 546 respectively in SEQ ID NO:6.

Claims (2)

1. An isolated, purified or recombinant nicking endonuclease comprising an amino acid sequence that can be encoded by a DNA at least 90% identical to SEQ ID NO:5, wherein said amino acid sequence does not have an arginine residue at a position corresponding to position 507 in SEQ ID NO:6 and does not have a glutamic acid residue at a position corresponding to position 546 in SEQ ID NO:6.

2. A nicking endonuclease according to claim 1 , wherein the amino acid sequence has an aspartic acid residue at a position corresponding to position 507 of SEQ ID NO:6 and a valine residue at a position corresponding to position 546 of SEQ ID NO:6.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2023
From: XU, SHUANG-YONG; ZHU, ZHENYU; MEIXSELL, TIMOTHY
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 064563/0148 →